hrp0095p1-460 | Diabetes and Insulin | ESPE2022

Assessing the clinical effectiveness of advanced hybrid closed loop insulin pump therapy and calibration-free glucose sensor - experience of a single centre, Arendal, Norway

Rojnic Putarek Natasa , Schmidt Katharina , Henrik Augustsson Johan , Hurvenes Moen Hilde , Spehar Uroic Anita

Introduction: Automated insulin delivery has demonstrated improved glycemic control in children and adolescents with type 1 diabetes mellitus (T1DM). The present analysis investigates real-world glycemic outcomes in children and adolescent on the MiniMed™ 780G advanced hybrid closed loop (AHCL) system after switching from MiniMed™ 640G predictive low glucose suspend system (PLGS) or MiniMed 670G hybrid closed loop (HCL) system and calibration-free ...

hrp0095p1-68 | Fat, Metabolism and Obesity | ESPE2022

Gender variability and associations of blood dopamine, leptin and insulin in overweight children.

Viazava Liudmila , Solntsava Anzhalika

Background: Some neuropeptides and hormones, for instance dopamine, leptin and insulin can affect the food consumption, eating behavior and can lead to obesity. Research goal was to discover the gender differences, associations and joint influence on body weight of blood dopamine (DA), leptin (LP) and insulin (Ins) concentrations in obese children.Material and methods: We discovered cross-sectional retrospective data of ...

hrp0095p1-513 | Growth and Syndromes | ESPE2022

Long-term effectiveness and safety of childhood growth hormone treatment in Turner syndrome from two large observational studies

Backeljauw Philippe , Pietropoli Alberto , Rohrer Tilman

Patients with Turner syndrome (TS) have short stature, despite having normal growth hormone (GH) secretion. Treatment with recombinant human GH is recommended. The effectiveness and safety of Norditropin® (somatropin, Novo Nordisk) over ≤10 years of follow-up were investigated in two non-interventional studies: NordiNet® IOS (NCT00960128) and the ANSWER Program (NCT01009905). Of 2,409 children with TS, 2,377 were included in the full analysis s...

hrp0095p2-101 | Fat, Metabolism and Obesity | ESPE2022

Epicardial fat, interventricular septal and leftventricular posterior wall thicknesses are associated with cardiometabolic risk markers and physical activity in apparently healthy school-age children

Vasileva Fidanka , Carreras-Badosa Gemma , Serrano-Ferrer Juan , Gómez-Vilarrubla Ariadna , Mas-Parés Berta , Osiniri Inés , Bassols Judit , Font-Llado Raquel , López-Bermejo Abel , Prats-Puig Anna

Introduction: Inactivity in children is associated with cardiometabolic risk, while physical activity improves cardiometabolic health. We aimed to determine the association between epicardial fat (Efat), interventricular septal and left ventricular posterior wall thicknesses (IVSthickness and LVPWthickness) with physical activity/inactivity, non-sedentary/sedentary behavior, body composition, and cardio-metabolic parameters in children classified as being: ina...

hrp0097t12 | Section | ESPE2023

Correlation between Metabolites of phthalate and Obese trends in Korean Children and Adolescents using Nationwide data

Eun Kim Ki , Eom Sang-Yong , Park Jung-Duk , Choi Byung-Sun , Hong Yong-Seob , Pyo Hee-Seob , Shin Hye-Jung

The aim of this study was to investigate that exposure metabolites of phthalate one of the endocrine disruptors might be different in sex and might have influenced from obesity and insulin resistance in Korean children and adolescents. Nationwide data of 551 subjects aged 8-15 years (boys 281 and girls 270) who were included the study from 2010-2011. Subjects were grouped by sex and BMI percentile (normal: BMI<85p; overweight: 85P≤BMI<95p; obese: ≥95p). We...

hrp0097p1-433 | Diabetes and Insulin | ESPE2023

Effects of triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy on glucose metabolism in cystic fibrosis patients

Yesquen Pamela , Campos Ariadna , Mogas Eduard , Yeste Diego , Gartnet Silvia , Clemente María

Introduction: Triple CFTR modulator therapy has been shown to improve lung function and quality of life in patients with at least one F508del mutation in the CFTR gen. However, effects on glucose metabolism are not yet well defined. This paper aims to describe the effects of this treatment on glucose metabolism in CF patients.Methodology: Ambispective study.Inclusion criteria: pati...

hrp0097p1-292 | GH and IGFs | ESPE2023

Clinical predictors of good/poor response to growth hormone treatment (GHT) in children with idiopathic short stature (ISS)

Dauber Andrew , Phillip Moshe , Ferran Jean-Marc , Kelepouris Nicky , Nedjatian Navid , Helene Olsen Anne , Jorge Alexander

Children with ISS vary in their response to GHT. We conducted a post hoc analysis to identify clinical characteristics associated with very good or poor response during year 1 of GHT in a subset of 1550 GH naïve children with ISS from NordiNet® IOS (NCT00960128) and the ANSWER Program (NCT01009905). We included patients aged 3–11 years (males) or 3–10 years (females) at treatment start, prepubertal throughout year 1 of treatment, with height SDS...

hrp0097p1-511 | Growth and Syndromes | ESPE2023

Pathway to assess severe primary IGF-1 deficiency diagnosis by using the IGF-1 generation test in a real-life setting: data from the Global Increlex® Registry

De Schepper Jean , Bossowski Artur , Argente Jesús , Sert Caroline , Perrot Valérie , Pennestri Daniele , Bang Peter

Background: severe primary insulin-like growth factor-1 deficiency (SPIGFD) is a rare growth disorder, for which insulin-like growth factor-1 (IGF-1) generation test (IGFGT) is debated as a complementary diagnostic analysis. Diagnostic workup for SPIGFD varies geographically and diagnosis is delayed by the rarity of the condition (<1/10,000). Evaluation of real-world practices of IGFGT could help facilitate diagnosis and test use. Objective: to describe rea...

hrp0097p1-357 | Pituitary, Neuroendocrinology and Puberty | ESPE2023

Evaluation of the pituitary gland in patients with Fanconi Anemia

Corredor Andrés Beatriz , Solis Muñiz Inés , Zubicaray Josune , Martín Rivada Álvaro , Barrios Sabador Vicente , Sevilla Julián , Argente Jesús

Introduction: Fanconi anemia (FA) is a genomic instability syndrome associated with congenital abnormalities. Structural anomalies of the central nervous system (CNS), particularly a small pituitary gland, have been published in a few case series. This has been thought to be the cause of the short stature (SS) observed in FA.Methods: A cross-sectional exploratory study was carried out in pediatric patients at the FA Span...

hrp0097p2-162 | GH and IGFs | ESPE2023

Correlation between IGF-1 at diagnosis and adult height in children with short stature

Incandela Valeria , Lussu Anna , Guzzetti Chiara , Ibba Anastasia , Loche Sandro , Casula Letizia

Background: Insulin-like Growth Factor-1 (IGF-1) is an amino acid peptide produced under the effect of Growth Hormone (GH), mostly secreted by the liver, which stimulates bone growth. IGF-1 levels have high specificity and low sensitivity for the diagnosis of Growth Hormone Deficiency (GHD). Higher IGF-1 levels are classically associated with a better response to growth hormone therapy. The aim of this study was to investigate the correlation between serum IGF...